drugset / Trial / NCT07848035

Injectable Platelet-Rich Fibrin and Microneedling With or Without Vitamin C for Gingival Phenotype Augmentation.

NCT07848035 ↗

Not yet recruiting 27 enrolled University of Science and Technology, Yemen
RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized split-mouth clinical trial will evaluate whether adding locally injected vitamin C to injectable platelet-rich fibrin (i-PRF) and microneedling improves gingival tissue thickness and keratinized tissue width in women with a thin gingival phenotype in the lower front teeth region. Each participant will receive i-PRF and microneedling on both sides of the lower anterior region. One side will additionally receive vitamin C, while the opposite side will receive normal saline as a placebo. The treatment will be repeated after 4 weeks. Gingival measurements will be taken at baseline, 3 months, and 6 months after the second treatment session. Patient satisfaction will also be assessed during follow-up.

Timeline

Start
2026-10
Primary completion
2027-07
Completion
2027-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified — Other
Background injectable platelet-rich fibrin (i-PRF) Unknown — Other

Indications

No indication recorded.